Key Market Segments
By Drug Class Type
-
Anti-inflammatory
-
Antihyperglycemics
-
NSAIDs
-
Interferons
-
Others
By Indication
-
Rheumatic Disease
-
Type 1 Diabetes
-
Multiple Sclerosis
-
Inflammatory Bowel Disease
-
Other Indications
By Sales Channel
-
Hospital Pharmacy
-
Drug Store & Retail Pharmacy
-
Online Store
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America led the market in 2025, supported by the high prevalence of rheumatoid arthritis, lupus, and multiple sclerosis, the robust healthcare system, and the general public's awareness of autoimmune health.
Ans: By indication, Rheumatic Disease dominated with 36.52% market share in 2024, while Inflammatory Bowel Disease is the fastest-growing, projected at a CAGR of 6.34%.
Ans: Rising prevalence of autoimmune disorders, including rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and inflammatory bowel disease, on account of genetic predisposition, environmental factors, and lifestyle changes are impacting the growth of the market.
Ans: The autoimmune disease therapeutics market size is estimated at USD 80.54 billion in 2025 and is expected to reach USD 123.80 billion by 2033, growing at a CAGR of 5.52%.
Ans: The Autoimmune Disease Therapeutics Market is projected to grow at a CAGR of 5.52% from 2026 to 2033, driven by biologics, biosimilars, and precision medicine.